Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Bioimpedance Spectroscopy for Fluid Changes in Hemodialysis Patients

Official title: Bioimpedance Spectroscopy (BIS): Analysis of Changes in Fluid Status in Hemodialysis Patients

Run by University of Aarhus · NCT07803029 · Data updated 2026-11-12

This study tests whether raw bioimpedance data can help doctors gauge fluid changes in people on hemodialysis and guides fluid removal decisions.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment42 (estimated)
SponsorUniversity of Aarhus
Academic / other
Locations1 site (Aarhus, Central Denmark)
StatusRecruiting
StartedMay 11, 2025
Main results expectedOctober 16, 2026
Study endsDecember 31, 2026
Registry record updatedSeptember 3, 2026
Trial IDNCT07803029 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults on hemodialysis for more than 3 months who are hemodynamically stable during dialysis sessions.

Probably not a fit

Patients with implanted electronic devices, amputations, significant limb limitations, or inability to consent may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study analyzes raw impedance measurements from BIS devices to see if they accurately reflect changes in body fluid status during dialysis. It compares data across multiple BIS devices and examines correlations with absolute blood volume, blood pressure, and weight changes over three consecutive dialysis sessions. The goal is to determine if BIS-derived metrics can reliably estimate fluid shifts in both center and home dialysis settings. The study also explores consistency of impedance metrics across devices and days in patients with and without fluid retention. Home versus center dialysis comparisons aim to identify potential practical implications for clinical practice.

Why it matters

Potential benefit: If successful, BIS-based measurements could provide a more accurate, device-independent way to monitor fluid status and tailor ultrafiltration during dialysis.

How similar studies have gone: Past small studies have suggested that raw BIS data may improve fluid status estimation, but broader validation across devices is needed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Hemodialysis for more than 3 month Hemodynamic stabile during a dialysis session

\-

Exclusion Criteria:

1. Amputated limbs.
2. Pregnant.
3. Extremity palsy and paralysis.
4. Implanted electronic device (e.g., pacemaker or ICD).
5. Regular use of dialysate sodium proliferation.
6. Hip, knee and shoulder prosthesis.
7. Dialysis fistula in both arms.
8. Inability to give informed consent.
9. History of discontinuation of dialysis treatment prematurely.

Where it's running

  • Aarhus University Hospital
    Aarhus, Central Denmark, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.